RE: Buyout is coming !!!
Interesting article bur Endo is not alone, eg - Eli Lilly was betting on an Alzheimer drug that has to be halted, and, must face generic version of their ADD drug (
https://www.reuters.com/article/idUSN1214829920100812 )... they plan to reduce their cost by 1 billion $$$ by the end of 2011...
if MCC works, then any majors could try a takeover - since they can developp by themselves MCC, not sure that Endo could take a part of anything but Urocidin
Urocidin success wil change the game
about royalties for Opana... hoping that BNC's are of the same order:
"Having bought Penwest, Endo can now make all the decisions about Opana without consultation. It also won't need to pay Penwest the 22% in royalties that were part of the previous partnership deal."